| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1031641041 |
| P356 | DOI | 10.1186/S13054-015-0905-X |
| P932 | PMC publication ID | 4421996 |
| P698 | PubMed publication ID | 25927915 |
| P5875 | ResearchGate publication ID | 275666588 |
| P50 | author | Martin Hoenigl | Q39596208 |
| Dieter Buchheidt | Q40279734 | ||
| Juergen Prattes | Q57145459 | ||
| Birgit Spiess | Q88456444 | ||
| P2093 | author name string | Susanne Eigl | |
| Mark Reinwald | |||
| Cornelia Lass-Flörl | |||
| Robert Krause | |||
| Albert Wölfler | |||
| Reinhard B Raggam | |||
| Birgit Willinger | |||
| Peter Neumeister | |||
| Frederike Reischies | |||
| Michaela Lackner | |||
| Christopher R Thornton | |||
| Stephan Eschertzhuber | |||
| Michael Meilinger | |||
| Brigitte Selitsch | |||
| Holger Flick | |||
| P2860 | cites work | Invasive aspergillosis in the intensive care unit | Q28306909 |
| Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. | Q33703531 | ||
| Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. | Q34085884 | ||
| Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders. | Q34430636 | ||
| Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes | Q34559978 | ||
| Incidence of Cyp51 A key mutations in Aspergillus fumigatus-a study on primary clinical samples of immunocompromised patients in the period of 1995-2013 | Q35215022 | ||
| Advances and challenges in management of invasive mycoses | Q36259905 | ||
| Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology | Q36286567 | ||
| Interlaboratory and interstudy reproducibility of a novel lateral-flow device and influence of antifungal therapy on detection of invasive pulmonary aspergillosis. | Q36559047 | ||
| Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study | Q36633947 | ||
| Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis | Q36746929 | ||
| Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project) | Q36898053 | ||
| Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ | Q37164067 | ||
| Risk stratification for invasive aspergillosis: early assessment of host susceptibility | Q37404681 | ||
| Comparison of lateral flow technology and galactomannan and (1->3)-beta-D-glucan assays for detection of invasive pulmonary aspergillosis | Q37450831 | ||
| ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients | Q37934487 | ||
| Approach to invasive pulmonary aspergillosis in critically ill patients | Q38186970 | ||
| Serum and urine galactomannan testing for screening in patients with hematological malignancies | Q38979166 | ||
| Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases. | Q39367515 | ||
| Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis in solid organ transplant patients: a semiprospective multicenter study | Q39596150 | ||
| Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis | Q39697409 | ||
| Sputum and bronchial secretion samples are equally useful as bronchoalveolar lavage samples for the diagnosis of invasive pulmonary aspergillosis in selected patients | Q40171946 | ||
| Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid | Q41368785 | ||
| Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients | Q41998776 | ||
| Invasive aspergillosis in patients with severe alcoholic hepatitis | Q42246970 | ||
| Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study | Q43631437 | ||
| Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006-2008). | Q44020369 | ||
| Aspergillus in the lower respiratory tract of immunocompetent critically ill patients | Q44886088 | ||
| Galactomannan in bronchoalveolar lavage for diagnosing invasive fungal disease. | Q45163172 | ||
| Comparison of a novel Aspergillus lateral-flow device and the Platelia® galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation. | Q45366904 | ||
| A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients | Q46059175 | ||
| Bronchoalveolar lavage fluid sample pretreatment with Sputasol(®) significantly reduces galactomannan levels. | Q46083243 | ||
| Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality | Q49124894 | ||
| Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients. | Q51175429 | ||
| Systemic antifungal therapy in critically ill patients without invasive fungal infection*. | Q51177612 | ||
| The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. | Q53195957 | ||
| Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies. | Q53220585 | ||
| Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis | Q53458650 | ||
| The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients. | Q53465238 | ||
| Galactomannan in Bronchoalveolar Lavage Fluid | Q57559940 | ||
| Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients | Q57937345 | ||
| Invasive aspergillosis in critically ill patients without malignancy | Q80269940 | ||
| P921 | main subject | aspergillosis | Q259626 |
| multicenter clinical trial | Q6934595 | ||
| invasive pulmonary aspergillosis | Q54946623 | ||
| P304 | page(s) | 178 | |
| P577 | publication date | 2015-04-17 | |
| P1433 | published in | Critical Care | Q5186602 |
| P1476 | title | Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients | |
| P478 | volume | 19 |
| Q47645142 | Aspergillosis in Chronic Granulomatous Disease. |
| Q49546197 | Aspergillus in airway material : Ignore or treat? |
| Q35984298 | Aspergillus infection monitored by multimodal imaging in a rat model. |
| Q89509794 | Blood Aspergillus PCR: The Good, the Bad, and the Ugly |
| Q60364596 | Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings |
| Q49604618 | Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review. |
| Q37659157 | Challenges in microbiological diagnosis of invasive Aspergillus infections |
| Q41996921 | Clinical evaluation of the newly formatted lateral-flow device for invasive pulmonary aspergillosis |
| Q37040538 | Detection of Aspergillus fumigatus in Blood Samples from Critically Ill Patients in Intensive Care Units by Use of the SeptiFast Assay |
| Q38853348 | Diagnostic of Fungal Infections Related to Biofilms |
| Q38723910 | Diagnostics and susceptibility testing in Aspergillus |
| Q38738085 | Early diagnosis of invasive mould infections and disease |
| Q38983367 | Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis. |
| Q38867587 | Immunoproteomics of Aspergillus for the development of biomarkers and immunotherapies |
| Q91762013 | Influenza H1N1 infection in immunocompromised host: A concise review |
| Q39367482 | Invasive aspergillosis in patients with underlying liver cirrhosis: a prospective cohort study |
| Q39062930 | Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status. |
| Q64228957 | New Concepts in Diagnostics for Invasive Mycoses: Non-Culture-Based Methodologies |
| Q52615929 | Non-culture based assays for the detection of fungal pathogens. |
| Q26746020 | Point of Care Testing for the Diagnosis of Fungal Infections: Are We There Yet? |
| Q90628627 | Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus-specific Lateral Flow Device test in bronchoalveolar lavage |
| Q97427835 | Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment |
| Q52570071 | Serum galactomannan antigen as a prognostic and diagnostic marker for invasive aspergillosis in heterogeneous medicine ICU patient population. |
| Q54214603 | Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy. |
| Q26753063 | The standard of care of patients with ARDS: ventilatory settings and rescue therapies for refractory hypoxemia |
| Q58765898 | Treatment of Aspergillosis |
Search more.